GetPortalImpactFactorByIdResp(projectId=1, id=332e2308, cover=https://img.medsci.cn/images/journal/cover/2021/zcj_202109271315000460.jpg, fullname=EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, abbr=EUR J PHARM BIOPHARM, pyear=1991, frequence=Monthly, articleNumbers=3953, citedSelf2015=4.3, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.67月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0939-6411, greenSci=https://www.greensci.net/search?kw=0939-6411, scijournal=https://www.scijournal.org/impact-factor-of-EUR-J-PHARM-BIOPHARM.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.26, medsciHotlight=4.643, medsciHotlight5year=7.78313, citescore=9.0, hIndex=158, impactFactor=4.9, orgnization=Elsevier, orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.elsevier.com/wps/find/journaldescription.cws_home/600120/description, websiteHits=9980, guideForAuthor=https://www.elsevier.com/journals/european-journal-of-pharmaceutics-and-biopharmaceutics/0939-6411/guide-for-authors, guideForAuthorHits=1419, submitWebsite=https://www.evise.com/evise/jrnl/EJPB, submitWebsiteHits=4718, content=<p style="box-sizing: border-box; margin: 0px 0px 0.25em; padding: 0px; vertical-align: baseline; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; user-select: text !important;">The <span style="box-sizing: border-box; line-height: inherit;">European Journal of Pharmaceutics and Biopharmaceutics</span> provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics.</p> <p style="box-sizing: border-box; margin: 0px 0px 0.25em; padding: 0px; vertical-align: baseline; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; user-select: text !important;">Topics covered include:</p> <p style="box-sizing: border-box; margin: 0px 0px 0.25em; padding: 0px; vertical-align: baseline; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; user-select: text !important;">• Drug and pro-drug design, drug stability and drug development<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Physical pharmacy, drug delivery systems, controlled release systems and drug targeting<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Biopharmaceutics<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Pharmaceutical analysis and pharmaceutical packaging<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Quality control, GMP and regulatory aspects<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> • Medical devices</p> <p style="box-sizing: border-box; margin: 0px 0px 0.25em; padding: 0px; vertical-align: baseline; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; user-select: text !important;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; user-select: text !important;">"The Rules of 3"</span><br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:</p> <p style="box-sizing: border-box; margin: 0px 0px 0.25em; padding: 0px; vertical-align: baseline; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; user-select: text !important;">1. The paper must report on recent advances in pharmaceutical technology, biopharmaceutics and pharmaceutical biotechnology of major importance<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> 2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.<br style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; user-select: text !important;"> 3. The study described in the manuscript must represent a novel approach</p> <p style="box-sizing: border-box; margin: 0px 0px 0.25em; padding: 0px; vertical-align: baseline; line-height: 1.625rem; text-rendering: optimizeLegibility; max-width: inherit; user-select: text !important;">The rules are also used as guidelines for the peer review of manuscripts. <a href="https://www.elsevier.com/__data/promis_misc/ejpbrulesof3.pdf" style="box-sizing: border-box; margin: 0px; padding: 0px; vertical-align: baseline; line-height: inherit; transition: all 111ms ease-out; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; word-break: break-word; word-wrap: break-word; user-select: text !important; border-bottom: none !important;">CLICK HERE</a> to view the "Rules of 3".</p>, totalCites=19374, brief=EUR J PHARM BIOPHARM杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的中等级别杂志, articleType=论著为主，其它类型文章约占5-10%, medsciHeat=黑红, medsciComment=EUR J PHARM BIOPHARM在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=332e2308'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=786, tagName=生物医药, createdHits=1), ImpactFactorTagDto(id=39012, tagName=药剂, createdHits=1), ImpactFactorTagDto(id=23440, tagName=生物药剂, createdHits=1), ImpactFactorTagDto(id=112, tagName=药学, createdHits=1), ImpactFactorTagDto(id=41472, tagName=药剂学, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=4.49), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.67), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.25), GetImpactFactorCiteScoreListResponse(year=2019, citescore=8.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=9.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=6.864), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=5.166), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=5.186), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=5.352), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.26)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science , rank=7/164), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Biotechnology , rank=25/257)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0939-6411[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS[ta], article_number=219, article_number_cn=34, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)